Clinical Trial Update: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pertuzumab with trastuzumab and chemotherapy in HER2-positive advanced gastric cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-27